Edition:
United States

STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

16.00USD
9:56am EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$16.00
Open
$16.00
Day's High
$16.00
Day's Low
$15.90
Volume
22,806
Avg. Vol
36,498
52-wk High
$17.60
52-wk Low
$8.95

Select another date:

Wed, Nov 8 2017

BRIEF-Staar Surgical reports Q3 earnings per share $0.03

* Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S

BRIEF-Staar surgical appoints Scott Barnes, M.D. as chief medical officer

* Staar surgical appoints Scott Barnes, M.D. as chief medical officer Source text for Eikon: Further company coverage:

BRIEF-Staar Surgical names Deborah Andrews as CFO

* Deborah Andrews, interim CFO, has agreed to resume her role as Chief Financial Officer for company​ Source text for Eikon: Further company coverage:

BRIEF-STAAR Surgical, Seoul/Busan BalGeunSeSang eye clinic announce strategic cooperation agreement

* STAAR Surgical and Seoul/Busan Balgeunsesang eye clinic announce strategic cooperation agreement

BRIEF-Staar Surgical Q2 loss per share $0.02

* Q2 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Staar Surgical to pay $7 million in investor suit over FDA violations

Staar Surgical Co, a manufacturer of implantable lenses to correct vision problems, has agreed to pay $7 million to resolve a lawsuit claiming the company misled investors about its compliance with Food and Drug Administration regulations.

Select another date: